Migraine Trial, Recruiting NCT07694063 Sponsor: University of Seville Condition: Migraine
Back to Migraine

Migraine Trial, Recruiting

NCT07694063
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 18 and 65 years old
  • People who have been diagnosed with episodic high-frequency migraine, based on recognised international diagnostic guidelines
  • People whose migraine diagnosis has been confirmed by a neurologist
  • People who have had migraines for at least one year
  • People who have been on a stable medication plan for at least 3 months before joining the trial
  • People who are willing to keep their medications unchanged during the study
  • People who are able to understand the study procedures and complete the required assessments
  • People who have signed a consent form agreeing to take part
  • People who are willing to be randomly assigned to a study group

Who may not be able to join:

  • People who have other significant neurological conditions
  • People who have severe mental health conditions that could affect their ability to take part
  • People who have a medical reason why moderate physical activity would not be safe for them
  • People who have chronic migraine, meaning 15 or more headache days per month
  • People who are currently using more than one medication to prevent migraines
  • People who do not have a sufficient understanding of the Spanish language
  • People who do not have internet access or the digital skills needed to take part in the online parts of the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Cristina García Muñoz, PhD, University of Seville

Phone: +34954551468

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Seville
Registry
ClinicalTrials.gov
Start date
27 January 2026
Est. completion
30 October 2026

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Migraine Frequency; Migraine Pain Intensity; Functional Impact of Migraine; Percentage of Completed Yoga Sessions; Exercise Adherence Rating Scale Score; PADEX Checklist Score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov